13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 66 holding rows worth $147,309,631.
- Accession
- 0001420506-24-000382
- Filer
- CIK 1746382
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 66 entries on the cover page, a total value of $147,309,631 stated on the cover page (in dollars after the unit check, H1), rows summing to $147,309,631 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 290,535 | $13,382,042 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 2,660,000 | $11,491,200 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 138,000 | $10,983,420 | dollars as filed | |
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 92,700 | $9,747,405 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 615,000 | $9,458,700 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 8,027,593 | $9,071,180 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 385,000 | $6,471,850 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,333,000 | $6,265,100 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 676,000 | $6,219,200 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 413,607 | $5,802,906 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 730,000 | $5,606,400 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 71,000 | $5,085,020 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,095,000 | $4,949,400 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 104,909 | $4,222,587 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 120,000 | $3,718,800 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 80,000 | $3,370,400 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 25,000 | $3,148,750 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 111,000 | $2,621,820 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 483,181 | $2,531,634 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 65,000 | $2,312,700 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 200,000 | $2,174,000 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 344,471 | $1,770,581 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 119,526 | $1,759,423 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 20,000 | $1,669,800 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 78,723 | $1,500,460 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 2,000,000 | $1,440,000 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 66,981 | $1,298,092 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 31,210 | $1,284,604 | dollars as filed | |
| FORTRESS BIOTECH INC | 34960Q307 | COM NEW | 405,122 | $1,219,417 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C957 | COM | 47,000 | $1,057,970 | dollars as filed | put |
| DIAMEDICA THERAPEUTICS INC | 25253X207 | COMMON STOCK | 287,698 | $817,062 | dollars as filed | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 200,000 | $680,000 | dollars as filed | |
| ACURX PHARMACEUTICALS INC | 00510M954 | PUT | 170,300 | $652,249 | dollars as filed | put |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 740,000 | $640,100 | dollars as filed | |
| ADVISORSHARES TR | 00768Y453 | PURE US CANNABIS | 80,000 | $560,800 | dollars as filed | |
| BIOXCEL THERAPEUTICS INC | 09075P955 | COM | 169,200 | $499,140 | dollars as filed | put |
| DOUBLEDOWN INTERACTIVE CO LT | 25862B109 | ADS | 60,876 | $447,408 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 6,485 | $298,115 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 13,000 | $292,630 | dollars as filed | |
| TONIX PHARMACEUTICALS HL | 890260854 | COM | 540,025 | $217,630 | dollars as filed | |
| NEXGEL INC | 65344E115 | *W EXP 12/27/202 | 225,000 | $110,250 | dollars as filed | |
| CYCLACEL PHARMACEUTICALS INC (US) OLD | 23254L801 | COM NEW | 37,982 | $101,412 | dollars as filed | |
| WEARABLE DEVICES LTD | M97838110 | *W EXP 09/14/202 | 1,411,600 | $98,812 | dollars as filed | |
| NOCTURNE ACQUISITION CORP | G6580S106 | RIGHT 12/26/2025 | 500,000 | $82,400 | dollars as filed | |
| SADOT GROUP INC | 627333107 | COM | 168,235 | $67,378 | dollars as filed | |
| ONFOLIO HOLDINGS INC | 68277K124 | *W EXP 01/02/202 | 200,000 | $16,000 | dollars as filed | |
| NOVABAY PHARMACEUTICALS INC | 66987P300 | COM | 67,457 | $13,761 | dollars as filed | |
| NLS PHARMACEUTICS LTD | H57830111 | *W EXP 02/02/202 | 200,000 | $11,220 | dollars as filed | |
| PEPPERLIME HEALTH ACQUSTN CO | G70021111 | *W EXP 10/01/202 | 367,500 | $11,062 | dollars as filed | |
| MOBIX LABS INC | 60743G118 | *W EXP 12/21/202 | 150,000 | $10,530 | dollars as filed | |
| Cingulate Inc W Exp 12/10/202 | 17248W113 | Warrant | 270,000 | $8,100 | dollars as filed | |
| BITCOIN DEPOT INC | 09174P113 | *W EXP 06/30/202 | 50,000 | $7,250 | dollars as filed | |
| Cdt Equity Inc W Exp 09/22/202 | 20678X114 | SPAC Combination | 100,000 | $6,930 | dollars as filed | |
| PROSOMNUS INC | 50535E116 | *W EXP 04/20/202 | 150,000 | $4,260 | dollars as filed | |
| DIGITAL HEALTH ACQUISITION C | 253893119 | *W EXP 99/99/999 | 150,000 | $3,908 | dollars as filed | |
| CYCURION INC | 95758L115 | *W EXP 02/13/203 | 100,000 | $3,190 | dollars as filed | |
| CEA INDUSTRIES INC | 86887P119 | *W EXP 02/11/202 | 250,000 | $2,988 | dollars as filed | |
| TG VENTURE ACQUISITION CORP | 87251T117 | *W EXP 08/15/202 | 200,000 | $2,960 | dollars as filed | |
| NEXERA TECHNOLOGIES LTD | M61472110 | *W EXP 08/26/202 | 68,681 | $2,589 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 82,233 | $1,443 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T107 | *W EXP 08/22/202 | 28,333 | $1,133 | dollars as filed | |
| NEXALIN TECHNOLOGY INC | 65345B110 | *W EXP 99/99/999 | 105,000 | $924 | dollars as filed | |
| TC BIOPHARM HOLDINGS PLC | 87807D111 | *W EXP 02/10/202 | 18,823 | $612 | dollars as filed | |
| BOA ACQUISITION CORP | g8059b119 | WT | 101,439 | $426 | dollars as filed | |
| BRUUSH ORAL CARE INC | 11750K120 | *W EXP 08/03/202 | 14,423 | $98 | dollars as filed | |
| Relativity Acquisition Corp | 75944B114 | Warrant | 100,000 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000382 | this filing | 2024-02-14 | acceptance time not in the bulk data set |